Posts tagged with 'pharma'
Biotech Party Continued On At Mid-YearBiotech and pharmaceuticals -- sometimes called biopharma -- had a strong first half of 2015. With few worries about tax law changes, a crop of new drug approvals, and investors pushing stock values ever-higher, Evaluate Pharma says it magnified "the view that the biotech party is never going to end."Read the rest of this entry »
The Pharma and Biotech Half-Year Review from EP Evaluate said most of the financial measures for the sector were strongly …
Researchers On the Track Of A Universal Flu VaccineCould the holy grail of flu protection be within reach?Read the rest of this entry »
Two different groups of researchers have achieved promising results toward development of a one-shot vaccine to protect against all influenza viruses.
Using different approaches, but targeting the same protein -- hemagglutinin, found on the surface of the flu virus H1N1 -- the two teams of researchers found their vaccines provided partial, and in some cases, complete protection against a variety …
How Pharma Can Hire High Potential TalentWho isn't looking for high potential workers?Read the rest of this entry »
Everyone is, of course.
In the world of pharmaceuticals, hiring the best and those who have the potential to be the best is not just a hope, but a core requirement for a company to be a player in the highly competitive industry where lives are at stake and earnings are measured in the billions. How to accomplish the recruitment of high potentials? …
New Reports Will Give Public Insight Into New Drug Costs, EffectivenessThe Institute for Clinical and Economic Review said it will soon begin releasing reports to the public on new high-impact drugs that will be an analysis of their clinical effectiveness, their cost, and the potential economic impact they'll have on the healthcare system.Read the rest of this entry »
The Institute says it expects to issue between 15 and 20 reports on the value of new drugs at about the same time the Food and Drug …
Outlook for Pharma, Biotech "In Very Good Shape"Worldwide prescription drug sales will reach almost a trillion dollars by 2020, according to Evaluate Pharma, a pharmaceutical industry research group. Growth is predicted to be just under 5% a year over the next five years.Read the rest of this entry »
"Standing at the midpoint of 2015, the pharma and biotech industry looks as if it is in very good shape, the patent cliff is firmly in the rear view mirror, and while it might …
Immunotherapy Drugs Hold Promise In Cancer FightCautioning that the results are early and the sample, in the liver trial, small, researchers are encouraged by the response to the cancer-fighting immunotherapy Nivolumab.Read the rest of this entry »
Presenting at the just concluded annual meeting of the American Society of Clinical Oncology, Bristol-Myers Squibb, which is trialing the drug, presented data suggesting that Nivolumab not only is helping lung cancer patients live longer, but it may also be effective in the treatment of …
Will Apple Make Clinical Trials Obsolete?Who's the newest player in the pharmaceutical industry?Read the rest of this entry »
Would you believe Apple? The Apple Watch has gotten attention for its design, powerful processor, and other techie wonders. It's potential for a game changer in the medical field has gotten less attention.
Less attention is not no attention and MacWorld itself suggests the watch may be a "game changer" for medical devices. Mashing up tech innovation with medical needs to come …
NIH Has Poor Record of Clinical Study TransparencyThe agency charged with responsibility for managing the clinical trials disclosure site ClinicalTrials.gov is among those worst at complying with the law mandating the transparency.Read the rest of this entry »
An analysis of compliance with the 2007 law requiring the posting of summary results of publicly and privately supported clinical studies, found that only 8.1% of trials funded by the government via the National Institutes for Health made it onto the site within the required …
Ahead for Pharma in 2015: Pricing Pressure, WearablesRead the rest of this entry »
"Pharma in 2015 will be defined as much by attempts to tackle the crises and trim the excesses that characterized 2014 as it will by the exciting new developments in disease treatments and healthcare technology."
So says Pharmaceutical Executive in an article that collects the best guesses of industry executives, analysts and consultants about the year ahead. To a large extent, most of the experts predict that 2015 will see …
Pharma Firms Turning to Contractors for MarketingRead the rest of this entry »
Pharmaceutical companies, like most industries, have been outsourcing certain functions for decades. Manufacturing has long been outsourced to pharmaceutical production firms, especially by the smaller drug companies. Now, market research is being outsourced, not to other companies, but to contractors who can handle short term projects, as well as avoid delays while vacancies on the marketing research team are filled. Market research contractors are also being engaged during the pre-clinical …